FDA's Lab-Developed Test Rule Faces High Hurdles
In a landmark proposed rule published last month,[1] the U.S. Food and Drug Administration announced plans to make explicit that in vitro diagnostic products, including in cases where the manufacturer of...To view the full article, register now.
Already a subscriber? Click here to view full article